User Surveillance in Ulcerative Colitis (CARE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01363453 |
Recruitment Status
:
Completed
First Posted
: June 1, 2011
Last Update Posted
: June 1, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Ulcerative Colitis |
Study Type : | Observational |
Actual Enrollment : | 500 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine |
Study Start Date : | October 2007 |
Actual Primary Completion Date : | May 2008 |
Actual Study Completion Date : | July 2008 |

Group/Cohort |
---|
Patients with Ulcerative Colitis |
- Prescription habits measured by daily dose of Mesalazine [ Time Frame: 0 - 8 weeks ]
- Compliance measured by questionnaire for drug intake [ Time Frame: 0 - 8 weeks ]
- Quality of Life measured by EuroQol Questionnaire [ Time Frame: 0 - 8 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- therapeutic need according to SPC
- written informed consent
Exclusion Criteria:
- contraindications according to SPC

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01363453

Study Director: | Clinical Development Support | Ferring Pharmaceuticals |
Responsible Party: | Clinical Development Support, Ferring Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT01363453 History of Changes |
Other Study ID Numbers: |
FE999907 |
First Posted: | June 1, 2011 Key Record Dates |
Last Update Posted: | June 1, 2011 |
Last Verified: | May 2011 |
Additional relevant MeSH terms:
Colitis Ulcer Colitis, Ulcerative Gastroenteritis Gastrointestinal Diseases |
Digestive System Diseases Colonic Diseases Intestinal Diseases Pathologic Processes Inflammatory Bowel Diseases |